These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 8299398)

  • 61. Cell kinetics in management of ovarian cancer.
    Torri V; Scorpiglione N
    Eur J Cancer; 1992; 29A(1):169-70. PubMed ID: 1445739
    [No Abstract]   [Full Text] [Related]  

  • 62. Early diagnosis of ovarian cancer.
    Oram DH; Jacobs IJ; Brady JL; Prys-Davies A
    Br J Hosp Med; 1990 Nov; 44(5):320, 322, 324. PubMed ID: 2275994
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [UL-scanning for ovarian cancer].
    Tabor A; Hornnes PJ; Ottesen BS
    Ugeskr Laeger; 1997 Mar; 159(10):1461-3. PubMed ID: 9082636
    [No Abstract]   [Full Text] [Related]  

  • 64. [Epithelial ovarian cancer: a challenge in gynecologic oncology].
    Dauplat J; Piccart M
    Pathol Biol (Paris); 1992 Nov; 39(9):823-4. PubMed ID: 1538891
    [No Abstract]   [Full Text] [Related]  

  • 65. [Impact of dose delivery of postoperative first-line chemotherapy on prognosis of stage III C epithelial ovarian carcinoma].
    Zhao XD; Zhang Q; Zhang Y
    Ai Zheng; 2005 Aug; 24(8):1002-5. PubMed ID: 16086882
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Prognostic value of the copper transporters, CTR1 and CTR2, in patients with ovarian carcinoma receiving platinum-based chemotherapy.
    Lee YY; Choi CH; Do IG; Song SY; Lee W; Park HS; Song TJ; Kim MK; Kim TJ; Lee JW; Bae DS; Kim BG
    Gynecol Oncol; 2011 Aug; 122(2):361-5. PubMed ID: 21570711
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Clinical and prognostic features of advanced ovarian carcinoma.
    Lund B
    Dan Med Bull; 1993 Nov; 40(5):537-45. PubMed ID: 8299398
    [No Abstract]   [Full Text] [Related]  

  • 68. Progressive epithelial ovarian carcinoma. Prognostic factors and clinical management.
    Grønlund B
    Dan Med Bull; 2006 Aug; 53(3):232-57. PubMed ID: 17092448
    [No Abstract]   [Full Text] [Related]  

  • 69. [Prognostic factors of ovarian cancer].
    Ochiai K
    Gan To Kagaku Ryoho; 2006 Dec; 33(13):2014-9. PubMed ID: 17197745
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Prognostic factors in ovarian epithelial cancer].
    Nishida T
    Gan To Kagaku Ryoho; 1996 May; 23(6):805-9. PubMed ID: 8645035
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Is there a standard therapy in advanced ovarian carcinoma?].
    Köchli OR
    Praxis (Bern 1994); 1999 Jan; 88(4):123-5. PubMed ID: 10067114
    [No Abstract]   [Full Text] [Related]  

  • 72. Primary surgery or neoadjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer.
    Vergote I; Amant F; Kristensen G; Ehlen T; Reed NS; Casado A
    Eur J Cancer; 2011 Sep; 47 Suppl 3():S88-92. PubMed ID: 21944035
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Pharmacotherapy in ovarian carcinoma].
    Pfisterer J; Du Bois A
    MMW Fortschr Med; 2005 Oct; 147(43):34-6. PubMed ID: 16302419
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.